Ticagrelor-related dyspnea genotype detection reagent or kit
A technology for dyspnea and ticagrelor, which is applied in the determination/inspection of microorganisms, biochemical equipment and methods, DNA/RNA fragments, etc., and can solve the problems of lack of detection methods for dyspnea
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0040] Example 1 Determination of CYP3A5 gene mutation site rs776746
[0041] 1. Collection of samples and arrangement of sample data
[0042] From January 2019 to October 2020, the inventor collected a large number of cases of patients taking ticagrelor who required long-term antiplatelet therapy after percutaneous coronary intervention for acute coronary syndrome at the First Affiliated Hospital of Naval Military Medical University. Blood samples from patients were collected, and demographic and clinical data of these samples were systematically collected.
[0043] The research sample selection criteria are as follows:
[0044] (1) 200 cases of acute coronary syndrome with definite symptoms of myocardial ischemia, ST segment change of ECG>1mm, significantly increased troponin, LVEF>50%, and definite diagnosis by coronary angiography;
[0045] (2) Exclude poor dependence, inability to take medicine regularly, or other underlying diseases that may easily cause dyspnea, such ...
Embodiment 2
[0072] Embodiment 2 Detection of ticagrelor-related dyspnea genotype
[0073] 1. Extraction of DNA samples from whole blood
[0074] The extraction steps are the same as those in the first embodiment.
[0075] 2. Quantitative PCR reaction
[0076] 1. PCR reaction system configuration
[0077] Configure the real-time quantitative PCR reaction system according to the standard shown in Table 4 below:
[0078] Table 4 Real-time fluorescence quantitative PCR reaction system
[0079]
[0080] 2. Real-time fluorescent quantitative PCR reaction
[0081] The real-time quantitative PCR reaction was carried out according to the following procedures
[0082] (1) Pre-denaturation conditions are: 95°C, 5 minutes;
[0083] (2) The amplification stage consists of 45 cycles, and the conditions are: denaturation: 95°C, 10 seconds; annealing: 60°C, 10 seconds; extension and fluorescence signal collection: 72°C, 10 seconds;
[0084] (3) The final melting curve was obtained according to ...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


